We are live on ! Find out more
SGMO

SANGAMO THERAPEUTICS INC
SGMO

Delisted

SGMO was delisted on the 4th of May, 2026.

Back to rankings

156 hedge funds and large institutions have $560M invested in SANGAMO THERAPEUTICS INC in 2015 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 53 increasing their positions, 47 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,968% more call options, than puts

Call options by funds: $142M | Put options by funds: $4.63M

13% more repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 47

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

9% less funds holding

Funds holding: 171 → 156 (-15)

32% less capital invested

Capital invested by funds: $825M → $560M (-$265M)

42% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 36

Holders
156
Holders Change
-15
Holders Change %
-8.77%
% of All Funds
4.2%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
21
Increased
53
Reduced
47
Closed
36
Calls
$142M
Puts
$4.63M
Net Calls
+$137M
Net Calls Change
-$54.5M

Top Buyers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
+$23.5M
2
State Street
State Street
Massachusetts
+$11.4M
3
CCI
Columbus Circle Investors
+$4.42M
4
Invesco
Invesco
Georgia
+$4.02M
5
VOYA Investment Management
VOYA Investment Management
Georgia
+$3.06M

Top Sellers

Rank Fund Capital Flow
1
JHIU
Janus Henderson Investors US
Colorado
-$17M
2
EAM
EverPoint Asset Management
Connecticut
-$14.9M
3
TCM
Tekla Capital Management
Massachusetts
-$7.79M
4
Allianz Asset Management
Allianz Asset Management
Germany
-$7.63M
5
First Eagle Investment Management
First Eagle Investment Management
New York
-$7.22M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$47.4M +$633K +49,134 +1%
State Street
2
State Street
Massachusetts
$37.7M +$11.4M +883,602 +35%
BBA
3
Baker Bros. Advisors
New York
$35.8M +$23.5M +1,826,388 +130%
WA
4
Wasatch Advisors
Utah
$34.3M +$397K +30,799 +1%
BFA
5
BlackRock Fund Advisors
California
$28.4M -$566K -43,871 -2%
Vanguard Group
6
Vanguard Group
Pennsylvania
$25.9M +$927K +71,937 +3%
FCM
7
Frontier Capital Management
Massachusetts
$21.1M -$3.42M -265,371 -12%
Bank of New York Mellon
8
Bank of New York Mellon
New York
$20.8M +$1.36M +105,856 +6%
BIT
9
BlackRock Institutional Trust
California
$20.2M -$1.13M -87,629 -5%
Jennison Associates
10
Jennison Associates
New York
$19.2M +$175K +13,577 +0.8%
Invesco
11
Invesco
Georgia
$15M +$4.02M +311,858 +30%
Adage Capital Partners
12
Adage Capital Partners
Massachusetts
$15M +$645K +50,000 +4%
RCM
13
RA Capital Management
Massachusetts
$13.5M – – –
VOYA Investment Management
14
VOYA Investment Management
Georgia
$10.8M +$3.06M +237,579 +32%
Goldman Sachs
15
Goldman Sachs
New York
$10.5M -$1.4M -108,218 -10%
PA
16
Perceptive Advisors
New York
$8.87M – – –
FC
17
FIC Capital
New York
$8.73M +$52.2K +4,050 +0.5%
Northern Trust
18
Northern Trust
Illinois
$8.72M -$97.4K -7,557 -1%
CCI
19
Columbus Circle Investors
$8.63M +$4.42M +342,676 +79%
Millennium Management
20
Millennium Management
New York
$8.49M +$272K +21,128 +3%
Franklin Resources
21
Franklin Resources
California
$7.94M – – –
Deutsche Bank
22
Deutsche Bank
Germany
$7.53M +$1.27M +98,541 +17%
TAM
23
Tiverton Asset Management
Delaware
$6.17M -$645K -50,000 -8%
UBS AM
24
UBS AM
Illinois
$5.76M -$33.5K -2,602 -0.5%
EAM
25
Eventide Asset Management
Massachusetts
$5.35M – – –
1
2 3 4 5

SGMO Hedge Fund Activity: Q2 2015 in Review

156 of the 3,713 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q2 2015, worth a combined $560M — down 32% from $825M a quarter earlier.

Sellers outnumbered buyers: 36 funds closed out of SGMO and 21 opened new positions — a net loss of 15 holders — while 47 trimmed existing stakes and 53 added.

The largest buyer was Baker Bros. Advisors, adding an estimated $23.5M. The largest seller was Janus Henderson Investors US, cutting an estimated $17M.

  • 156 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q2 2015, down from 171 in Q1 2015.
  • Funds reported $560M of SANGAMO THERAPEUTICS INC stock for Q2 2015, down 32% quarter-over-quarter.
  • 21 funds opened new SANGAMO THERAPEUTICS INC positions in Q2 2015 and 36 closed out, a net change of -15 holders.
  • The largest SANGAMO THERAPEUTICS INC buyer in Q2 2015 was Baker Bros. Advisors, an estimated $23.5M added.
  • The largest SANGAMO THERAPEUTICS INC seller in Q2 2015 was Janus Henderson Investors US, an estimated $17M sold.

Based on aggregated 13F filings for Q2 2015.